Drawing for PLENTIVECTOR

USPTO serial 76396372

PLENTIVECTOR

Reviewed by CopyMark Law Group

Reg. 2993591Status 710
Filing date
Status date
Registration date
Sep 13, 2005
Examiner
MANDIR, FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PLENTIVECTOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John B. Hardaway, III

JOHN B HARDAWAY III NEXSEN PRUET JACOBS & POLLARD, LLCP O BOX 10107GREENVILLE, SC 29603-0107UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical compositions containing nucleic acids for use in the manufacture of pharmaceutical and retroviral vector preparationsSECTION 8 - CANCELLED—
005Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystemSECTION 8 - CANCELLED—
042Scientific and medical product research and development, genetic engineering services for scientific and medical research use, biotechnology services, namely, research and development of new products in the field of biotechnology, genetic engineering services for scientific and medical research useSECTION 8 - CANCELLED—
044medical servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)—
Sep 13, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 21, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 1, 2005NPUBNOTICE OF PUBLICATION—
Mar 7, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 4, 2005ALIEASSIGNED TO LIE—
Feb 25, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 15, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 12, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 12, 2004MAILPAPER RECEIVED—
Mar 30, 2004CNSIINQUIRY AS TO SUSPENSION MAILED—
Dec 12, 2003CFITCASE FILE IN TICRS—
Apr 29, 2003CNSLLETTER OF SUSPENSION MAILED—
Feb 26, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance